Gene

Search results

No.	KEGG PATHWAY	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	African trypanosomiasis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
2	AGE-RAGE signaling pathway in diabetic complications 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
3	Alcoholic liver disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
4	Alzheimer disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
5	Amoebiasis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
6	Antifolate resistance 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
7	C-type lectin receptor signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
8	Chagas disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
9	Coronavirus disease - COVID-19 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
10	Cytokine-cytokine receptor interaction 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
11	Cytosolic DNA-sensing pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
12	Fluid shear stress and atherosclerosis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
13	Graft-versus-host disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
14	Hematopoietic cell lineage 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
15	Herpes simplex virus 1 infection 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
16	Human cytomegalovirus infection 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
17	IL-17 signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
18	Inflammatory bowel disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
19	Inflammatory mediator regulation of TRP channels 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
20	Influenza A 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
21	Legionellosis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
22	Leishmaniasis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
23	Lipid and atherosclerosis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
24	Malaria 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
25	MAPK signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
26	Measles 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
27	Necroptosis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
28	NF-kappa B signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
29	NOD-like receptor signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
30	Non-alcoholic fatty liver disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
31	Osteoclast differentiation 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
32	Pathogenic Escherichia coli infection 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
33	Pathways of neurodegeneration - multiple diseases 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
34	Pertussis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
35	Prion disease 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
36	Rheumatoid arthritis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
37	Salmonella infection 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
38	Shigellosis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
39	Th17 cell differentiation 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
40	TNF signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
41	Toll-like receptor signaling pathway 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
42	Tuberculosis 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
43	Type I diabetes mellitus 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬
44	Yersinia infection 💬	[1] IL1B 💬	Canakinumab 💬	Canakinumab	[10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 💬